BIOMAT Database Logo BIOMAT Database Logo

Acromegaly with 'normal' growth hormone levels. 1985

K R Feingold, and T J Lorenz

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000172 Acromegaly A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80) Inappropriate Growth Hormone Secretion Syndrome (Acromegaly),Somatotropin Hypersecretion Syndrome (Acromegaly),Inappropriate GH Secretion Syndrome (Acromegaly),Hypersecretion Syndrome, Somatotropin (Acromegaly),Hypersecretion Syndromes, Somatotropin (Acromegaly),Somatotropin Hypersecretion Syndromes (Acromegaly),Syndrome, Somatotropin Hypersecretion (Acromegaly),Syndromes, Somatotropin Hypersecretion (Acromegaly)
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin

Related Publications

K R Feingold, and T J Lorenz
Acromegaly with normal basal growth hormone levels.
August 1997, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques,
K R Feingold, and T J Lorenz
Acromegaly with normal growth hormone levels: response to Sandostatin-LAR treatment.
May 2000, Pituitary,
K R Feingold, and T J Lorenz
Acromegaly with normal growth-hormone levels and pituitary histology. Case report.
April 1979, Journal of neurosurgery,
K R Feingold, and T J Lorenz
Normal growth hormone secretion is rare after microsurgical normalization of growth hormone levels in acromegaly.
January 1982, Acta medica Scandinavica,
K R Feingold, and T J Lorenz
Acromegaly with normal fasting growth hormone concentrations but abnormal growth hormone regulation.
December 1974, Annals of internal medicine,
K R Feingold, and T J Lorenz
Acromegaly with 'normal' serum growth hormone levels. Clinical features, diagnosis and results of transsphenoidal microsurgery.
August 1992, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
K R Feingold, and T J Lorenz
Acromegaly with normal insulin-like growth factor I levels.
February 2006, Mayo Clinic proceedings,
K R Feingold, and T J Lorenz
Normal growth with subnormal growth-hormone levels.
September 1968, The New England journal of medicine,
K R Feingold, and T J Lorenz
Galanin decreases circulating growth hormone levels in acromegaly.
June 1992, The Journal of clinical endocrinology and metabolism,
K R Feingold, and T J Lorenz
Growth hormone levels in acromegaly after external radiotherapy.
June 1977, Archives of internal medicine,
Copied contents to your clipboard!